Sort by
Refine Your Search
-
Listed
-
Employer
- University of Oxford
- ;
- KINGS COLLEGE LONDON
- University of London
- Durham University
- UNIVERSITY OF VIENNA
- DURHAM UNIVERSITY
- Heriot Watt University
- King's College London
- University of Birmingham
- University of Liverpool
- ; University of Oxford
- Aston University
- St George's University of London
- University of Cambridge
- University of Lincoln
- 6 more »
- « less
-
Field
-
at the Faculty of Life Sciences for 6 years. The 'Molecular Targets Laboratory' led by Professor Verena M. Dirsch aims at a better understanding of the molecular mechanisms of natural products. Cell and molecular
-
Institute for Renewable Energy, Department of Chemistry, University of Liverpool. This is the joint project between UK (E.P.S.R.C. funding) and USA (NSF funding). The project is targeted on an ultrasonic
-
The Role Postdoctoral Research Associate: An exploration of the relationship between funding and medal targets, and athlete experience We are seeking to appoint a Postgraduate Research Assistant
-
the possibility of making “universal” vaccines by targeting these epitopes. We have validated this methodology for the influenza virus (https://www.nature.com/articles/s41467-018-06228-8) and the technology has
-
interpret high-resolution datasets that reveal new insights into disease progression, with the ultimate aim of identifying novel biomarkers and therapeutic targets. You will hold a relevant PhD/DPhil
-
immunity against epitopes of limited variability (ELV), thereby opening up the possibility of making “universal” vaccines by targeting these epitopes. We have validated this methodology for the influenza
-
into disease progression, with the ultimate aim of identifying novel biomarkers and therapeutic targets. You will hold a relevant PhD/DPhil, together with relevant knowledge in normal and malignant hematopoiesis
-
that reveal new insights into disease progression, with the ultimate aim of identifying novel biomarkers and therapeutic targets. This is a unique opportunity to work at the cutting edge of translational
-
that reveal new insights into disease progression, with the ultimate aim of identifying novel biomarkers and therapeutic targets. This is a unique opportunity to work at the cutting edge of translational
-
with different diseases in diverse populations and to identify potential therapeutic targets. This is an exciting opportunity to contribute to a programme of research that assess the causal relevance